National Bank of Canada FI Takes Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

National Bank of Canada FI purchased a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 159,400 shares of the real estate investment trust's stock, valued at approximately $6,488,000. National Bank of Canada FI owned approximately 0.06% of Omega Healthcare Investors at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in shares of Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 516 shares during the period. True Wealth Design LLC purchased a new stake in Omega Healthcare Investors during the 3rd quarter worth about $31,000. DiNuzzo Private Wealth Inc. bought a new position in Omega Healthcare Investors in the 3rd quarter worth about $33,000. V Square Quantitative Management LLC boosted its stake in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock worth $40,000 after purchasing an additional 323 shares during the period. Finally, Truvestments Capital LLC purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at about $43,000. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock traded up $0.41 during trading on Friday, hitting $39.21. 1,655,652 shares of the stock traded hands, compared to its average volume of 1,687,984. The stock has a market cap of $10.58 billion, a price-to-earnings ratio of 28.78, a PEG ratio of 1.21 and a beta of 0.98. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The firm's fifty day moving average is $40.38 and its 200-day moving average is $37.82.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's payout ratio is currently 197.06%.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Royal Bank of Canada increased their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target for the company in a report on Monday. Scotiabank upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a report on Monday, August 26th. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Finally, Mizuho upped their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a research note on Thursday, December 5th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $40.18.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.